GenoLogics Life Sciences Software Inc
15.10.2013 13:01:20 CEST | Globenewswire | Pressemeddelelse
Del
Photo Release -- GenoLogics Announces No-Cost Clarity Cloud Edition
Intuitive Lab Management Solutions Help Genomics Laboratories Contend With
Sequencing Challenges and Costs
VICTORIA, British Columbia, 2013-10-15 13:00 CEST (GLOBE NEWSWIRE) --
GenoLogics Life Sciences Software, a leading provider of laboratory information
management systems (LIMS) announced today the availability of three new
cloud-based lab management products: Clarity Run Manager, Clarity Run Manager
Plus, and the early access availability of Clarity LIMS Silver. These editions
are sized and priced to fit any genomics laboratory's budget (including a
no-cost version), with virtually instantaneous deployment. These editions
provide sample management and workflow tracking to support the use of Illumina®
or Life Technologies(TM) sequencing instruments or other genomics technologies.
A photo accompanying this release is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=21538
The advent of desktop sequencing has allowed small and mid-sized labs to
routinely provide sequencing services; however, until now there were limited
options for project, sample, and lab activity tracking. While most lab managers
and directors of these organizations would agree that they should have a LIMS
for their next generation sequencing (NGS) tests or services, most do not have
such a system due to the high-cost and complexity of traditional commercial
tools and/or the lack resources for internal development, implementation and
maintenance.
The three Clarity Cloud editions provide these organizations access to flexible
price and feature set options that can grow with a lab, are easy to use by
staff, and require no internal IT resources to configure, update or maintain.
The products range in price from the no-cost edition, Clarity Run Manager, to
the moderately priced wider LIMS feature set found in Clarity LIMS Silver
edition.
"Scientists and lab directors want to improve the efficiency and throughput of
their labs. They don't want to worry about managing technology resources or pay
for software features they don't currently need," said Michael Ball, CEO of
GenoLogics. "Providing these organizations with flexible, cloud-based offerings
allows customers to protect their investments in instruments and reagents, as
their labs grow."
To learn more about these new NGS LIMS options and for access to the no-cost
Clarity Run Manager application visit http://genologics.com/clarity-run-manager
About GenoLogics
GenoLogics is a leading provider of laboratory information management system
(LIMS) software specifically designed for genomics and mass spec research in
regulated and unregulated labs. Its recently introduced Clarity LIMS offers an
intuitive role-optimized interface and features that make it an invaluable
investment for labs that are regulated or CLIA-certified and have NGS
technologies. Founded in 2002, GenoLogics is uniquely qualified to meet the
current and future lab information management needs of modern genomics and mass
spec research laboratories. Privately held GenoLogics is based in Victoria,
British Columbia. More information at www.genologics.com.
The photo is also available via AP PhotoExpress.
Media Contact
Aubree Hoover
marketing@genologics.comInformation om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
Investeringsforeningen BankInvest21.4.2026 11:10:00 CEST | Pressemeddelelse
Investeringsforeningen BankInvest – Prospektopdatering
Kapitalforeningen BankInvest Select21.4.2026 11:10:00 CEST | Pressemeddelelse
Kapitalforeningen BankInvest Select – Prospektopdatering
Investeringsforeningen BankInvest21.4.2026 11:05:00 CEST | Pressemeddelelse
Forløb af ordinære generalforsamlinger i Investeringsforeningen BankInvest og Kapitalforeningen BankInvest Select
Kapitalforeningen BankInvest Select21.4.2026 11:05:00 CEST | Pressemeddelelse
Forløb af ordinære generalforsamlinger i Investeringsforeningen BankInvest og Kapitalforeningen BankInvest Select
Royal UNIBREW A/S21.4.2026 10:40:06 CEST | Press release
Q1 2026 trading statement
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum
